Clinical epidemiological aspects in patients with neonatal infection
Keywords:
newborn, neonatal infection, low birth weight, secondary health care.Abstract
A descriptive, prospective and cross-sectional study of 69 patients with neonatal infection, born in “Mariana Grajales Coello” Teaching Southern Maternal Hospital in Santiago de Cuba, was carried out from January, 2012 to December, 2013, aimed at characterizing them according to clinical epidemiological aspects. Among the main results the early onset of infection (72.5%), preterm low weight (82.6%), systemic infections (59.4%), vaginal infection as the most frequent maternal risk factor (47.8%), respiratory failure (50.7%), as well as the gramnegative pathogens as the main causative factors prevailed. The early onset of infections showed higher mortality, although in a global way there was a high survival.
Downloads
References
2. Cuba. Ministerio de Salud Pública. Normas de microbiología. La Habana: MINSAP; 2010.
3. Gardner SL. Sepsis in the neonate. Crit Care Nurs Clin North Am. 2009;21(1):121-41.
4. Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J Pediatr. 2008;75(3):261-6.
5. Cohen J, Brun Buisson C, Torres A, Jorgensen J. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med. 2004;32(11):66.
6. Stoll BJ. The global impact of neonatal infection. Clin Perinatol. 1997;24(1):1-21.
7. Díaz Álvarez M, Bello P, Portuondo M. Incidencia, morbilidad y mortalidad neonatal en recién nacidos de menos de 1 500 gramos de peso. Rev Cubana Pediatr. 1993;65(2):81-7.
8. Schrag S, Phill D, Schuchat PA. Prevention of neonatal sepsis. Clin Perinatol. 2005; 32(3):601-15.
9. Griffin MP, Lake DE, O’ Shea M, Moorman R. Heart rate characteristics and clinical signs in neonatal sepsis. Pediatr Res. 2007;61(2):222-7.
10. Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, et al. Neonatal infections in England: the NeoIN surveillance network. Arch Dis Child Fetal Neonatal. 2011;96(1):9-14.
11. Trotman H, Bell Y. Neonatal sepsis in very low birthweight infants at the university hospital of the West Indies. West Indian Med J. 2006;55(3):165-9.
12. Guzmán A, Abarzúa F, Belmar C, García P. Resultados de la aplicación del protocolo basado en screening para la búsqueda de Streptococcus agalactiae en el tercer trimestre del embarazo: posible impacto sobre la sepsis neonatal precoz por este agente. Rev Chil Infectol. 2001;18(3):187-92.
13. Mancilla J, Segura E. Antimicrobianos en recién nacidos. En: Arbo Sosa A, Santos Preciado JI. Antibióticos en pediatría. México, DF: Editorial Mc Graw Hill; 2008. p. 131-49.
14. Ramírez Sandoval MLP, Macías Parra M, Lazcano Ramírez F. Etiología de la sepsis neonatal en una unidad hospitalaria de segundo nivel. Salud Pública Méx. 2007; 49(6):391-3.
15. González MA, Caraballo MA, Guerrero SA. Sepsis neonatal y prematurez. Rev Posgrado VIa Cátedra Med. 2006;160:22-8.
16. Medina Mejía M, Hernández Ramos I, Nandí Lozano ME, Ávila Figueroa C. Infecciones nosocomiales en una unidad de cuidados intensivos neonatales. Perinatol Reprod Hum. 2000;14(3):143-50.
17. Miranda Novales MG. Resistencia antimicrobiana del Staphylococcus aureus en México. Bol Med Hosp Infant Mex. 2011;68(4):1-17.
18. Castellanos Madrid R, Aguilar Lanza MC. Ruptura prematura de membranas y su relación con sepsis neonatal precoz en recién nacidos de término. Rev Med Post UNAH. 2001;6(2):22-30.
19. Morayta Ramírez A, Escobar Rojas V, Gutiérrez Muñoz J. Incidencia de infecciones nosocomiales y patrones de sensibilidad in vitro en el Servicio de Pediatría del Hospital “20 de Noviembre”. Rev Enferm Infecc Ped. 2001;15(57):14-22.
20. Shimabuku R, Velásquez P, Yábar J, Zerpa R, Arribasplata G, Fernández S, et al. Etiología y susceptibilidad antimicrobiana de las infecciones neonatales. An Fac Med. 2004;65(1):19-24.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.